000894073 001__ 894073
000894073 005__ 20240701202017.0
000894073 0247_ $$2doi$$a10.3390/ijms22137066
000894073 0247_ $$2ISSN$$a1422-0067
000894073 0247_ $$2ISSN$$a1661-6596
000894073 0247_ $$2Handle$$a2128/28208
000894073 0247_ $$2altmetric$$aaltmetric:109088698
000894073 0247_ $$2pmid$$a34209129
000894073 0247_ $$2WOS$$aWOS:000671088200001
000894073 037__ $$aFZJ-2021-03023
000894073 082__ $$a540
000894073 1001_ $$0P:(DE-Juel1)164337$$aPost, Julia$$b0$$ufzj
000894073 245__ $$aOral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1G93A Transgenic Mice
000894073 260__ $$aBasel$$bMolecular Diversity Preservation International$$c2021
000894073 3367_ $$2DRIVER$$aarticle
000894073 3367_ $$2DataCite$$aOutput Types/Journal article
000894073 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1719815291_27748
000894073 3367_ $$2BibTeX$$aARTICLE
000894073 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000894073 3367_ $$00$$2EndNote$$aJournal Article
000894073 520__ $$aNeuroinflammation is a pathological hallmark of several neurodegenerative disorders and plays a key role in the pathogenesis of amyotrophic lateral sclerosis (ALS). It has been implicated as driver of disease progression and is observed in ALS patients, as well as in the transgenic SOD1G93A mouse model. Here, we explore and validate the therapeutic potential of the d-enantiomeric peptide RD2RD2 upon oral administration in SOD1G93A mice. Transgenic mice were treated daily with RD2RD2 or placebo for 10 weeks and phenotype progression was followed with several behavioural tests. At the end of the study, plasma cytokine levels and glia cell markers in brain and spinal cord were analysed. Treatment resulted in a significantly increased performance in behavioural and motor coordination tests and a decelerated neurodegenerative phenotype in RD2RD2-treated SOD1G93A mice. Additionally, we observed retardation of the average disease onset. Treatment of SOD1G93A mice led to significant reduction in glial cell activation and a rescue of neurons. Analysis of plasma revealed normalisation of several cytokines in samples of RD2RD2-treated SOD1G93A mice towards the levels of non-transgenic mice. In conclusion, these findings qualify RD2RD2 to be considered for further development and testing towards a disease modifying ALS treatment.
000894073 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000894073 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x1
000894073 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000894073 7001_ $$0P:(DE-Juel1)176527$$aSchaffrath, Anja$$b1$$ufzj
000894073 7001_ $$0P:(DE-Juel1)171922$$aGering, Ian$$b2
000894073 7001_ $$00000-0002-5225-6804$$aHartwig, Sonja$$b3
000894073 7001_ $$00000-0002-5575-4315$$aLehr, Stefan$$b4
000894073 7001_ $$0P:(DE-Juel1)131794$$aShah, N. J.$$b5$$ufzj
000894073 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b6
000894073 7001_ $$0P:(DE-Juel1)132029$$aWillbold, Dieter$$b7
000894073 7001_ $$0P:(DE-Juel1)159137$$aKutzsche, Janine$$b8
000894073 7001_ $$0P:(DE-Juel1)144347$$aWilluweit, Antje$$b9$$eCorresponding author
000894073 773__ $$0PERI:(DE-600)2019364-6$$a10.3390/ijms22137066$$gVol. 22, no. 13, p. 7066 -$$n13$$p7066 -$$tInternational journal of molecular sciences$$v22$$x1422-0067$$y2021
000894073 8564_ $$uhttps://juser.fz-juelich.de/record/894073/files/ijms-22-07066.pdf$$yOpenAccess
000894073 909CO $$ooai:juser.fz-juelich.de:894073$$popenaire$$pdnbdelivery$$pdriver$$pVDB$$popen_access
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)164337$$aForschungszentrum Jülich$$b0$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)176527$$aForschungszentrum Jülich$$b1$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171922$$aForschungszentrum Jülich$$b2$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b5$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b6$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132029$$aForschungszentrum Jülich$$b7$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)159137$$aForschungszentrum Jülich$$b8$$kFZJ
000894073 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144347$$aForschungszentrum Jülich$$b9$$kFZJ
000894073 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000894073 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x1
000894073 9141_ $$y2021
000894073 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000894073 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000894073 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J MOL SCI : 2019$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000894073 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000894073 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000894073 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
000894073 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x1
000894073 9201_ $$0I:(DE-Juel1)VDB1046$$kJARA-BRAIN$$lJülich-Aachen Research Alliance - Translational Brain Medicine$$x2
000894073 9201_ $$0I:(DE-Juel1)IBI-7-20200312$$kIBI-7$$lStrukturbiochemie$$x3
000894073 980__ $$ajournal
000894073 980__ $$aVDB
000894073 980__ $$aI:(DE-Juel1)INM-4-20090406
000894073 980__ $$aI:(DE-Juel1)INM-11-20170113
000894073 980__ $$aI:(DE-Juel1)VDB1046
000894073 980__ $$aI:(DE-Juel1)IBI-7-20200312
000894073 980__ $$aUNRESTRICTED
000894073 9801_ $$aFullTexts